Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury
Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury
复制标题
DOI:
10.1161/circulationaha.104.508333
复制
发表时间:
2005-07-19
期刊:
影响因子:
37.8
通讯作者:
Hohlfeld, T
中科院分区:
文献类型:
--
作者:
Martin, M;Meyer-Kirchrath, J;Hohlfeld, T
Background - The generation of prostaglandin E-2 (PGE(2)) is significantly increased in acute myocardial ischemia and reperfusion. PGE(2), in addition to other prostaglandins, protects the reperfused ischemic myocardium. It has been hypothesized that this cardioprotection is mediated by E-type prostaglandin receptors of the G(i)-coupled EP3 subtype.Methods and Results - We tested this hypothesis by generating transgenic ( tg) mice with cardiospecific overexpression of the EP3 receptor. According to ligand binding, a 40-fold overexpression of the EP3 receptor was achieved in membranes prepared from tg hearts compared with wild-type (wt) littermates. In isolated cardiomyocytes from tg mice, the forskolin-induced rise in cAMP was markedly attenuated, indicating coupling of the overexpressed EP3 receptor to inhibitory G proteins (G(i)) with constitutive receptor activity. There was no evidence for EP3 receptor coupling to G(q)-mediated protein kinase C signaling. Isolated hearts from tg and wt mice were subjected to 60 minutes of no-flow ischemia and 45 minutes of reperfusion. In tg hearts, ischemic contracture was markedly delayed compared with wt hearts, and the ischemia-induced increase in left ventricular end-diastolic pressure was reduced by 55%. Creatine kinase and lactate dehydrogenase release was significantly decreased by 85% and 73%, respectively, compared with wt hearts.Conclusions - Constitutive prostaglandin EP3 receptor signaling exerts a protective effect on cardiomyocytes, which is probably Gi mediated and results in a remarkable attenuation of myocardial injury during ischemia and reperfusion. Cardioprotective actions of E-type prostaglandins may be mediated by this receptor subtype.